Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 16;23(6):3188.
doi: 10.3390/ijms23063188.

Uric Acid and Oxidative Stress-Relationship with Cardiovascular, Metabolic, and Renal Impairment

Affiliations
Review

Uric Acid and Oxidative Stress-Relationship with Cardiovascular, Metabolic, and Renal Impairment

Mihai-Emil Gherghina et al. Int J Mol Sci. .

Abstract

Background: The connection between uric acid (UA) and renal impairment is well known due to the urate capacity to precipitate within the tubules or extra-renal system. Emerging studies allege a new hypothesis concerning UA and renal impairment involving a pro-inflammatory status, endothelial dysfunction, and excessive activation of renin-angiotensin-aldosterone system (RAAS). Additionally, hyperuricemia associated with oxidative stress is incriminated in DNA damage, oxidations, inflammatory cytokine production, and even cell apoptosis. There is also increasing evidence regarding the association of hyperuricemia with chronic kidney disease (CKD), cardiovascular disease, and metabolic syndrome or diabetes mellitus.

Conclusions: Important aspects need to be clarified regarding hyperuricemia predisposition to oxidative stress and its effects in order to initiate the proper treatment to determine the optimal maintenance of UA level, improving patients' long-term prognosis and their quality of life.

Keywords: cardiovascular risk; chronic kidney disease; outcome; oxidative stress; uric acid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Metabolism of purine through xanthine oxidoreductases. XO, xanthine oxidase; XDH, xanthine dehydrogenase; ROS, reactive oxygen species; NADH, nicotinamide adenine dinucleotide (Modified after: [23]).
Figure 2
Figure 2
(A) SMCT1 and SMCT2 reabsorb Na-dependent anions and raise intra-cellular concentration. URAT1/OAT10/OAT4 exchange intracellular anions with tubular urate, which will exit the cell via GLUT9. (B) Na and alpha-ketoglutarate will enter the cell through NADC3. Basolateral OAT1/OAT3 exchanges plasma urate with intracellular alpha-ketoglutarate. Intracellular urate exit is accomplished through voltage channels NPT1/NPT4 or ATP-driven MRP4. SMCT1,sodium-monocarboxylate co-transporter 1; SMCT2, sodium-monocarboxylate co-transporter 2; Na+, sodium; K+, potassium; URAT1, urate transporter 1; OAT10, organic anion transporter 10; OAT4, organic anion transporter 4; OAT1, organic anion transporter 1; OAT3, organic anion transporter 3; MRP4, multidrug resistance protein 4; ABCG2, adenosine triphosphate binding cassette subfamily G member 2; NPT1, Na-phosphate transporter 1; NPT4, Na-phosphate transporter 4; GLUT9, glucose transporter 9; NADC3, sodium-dependent dicarboxylate cotransporter 3 (Modified after [35]).

Similar articles

Cited by

References

    1. Adomako E., Moe O.W. Uric Acid and Urate in Urolithiasis: The Innocent Bystander, Instigator, and Perpetrator. Semin. Nephrol. 2020;40:564–573. doi: 10.1016/j.semnephrol.2020.12.003. - DOI - PMC - PubMed
    1. Jakše B., Jakše B., Pajek M., Pajek J. Uric Acid and Plant-Based Nutrition. Nutrients. 2019;11:1736. doi: 10.3390/nu11081736. - DOI - PMC - PubMed
    1. Caliceti C., Calabria D., Roda A., Cicero A. Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review. Nutrients. 2017;9:395. doi: 10.3390/nu9040395. - DOI - PMC - PubMed
    1. Choi H.K., Mount D.B., Reginato A.M. Pathogenesis of gout. Ann. Intern. Med. 2005;143:499–516. doi: 10.7326/0003-4819-143-7-200510040-00009. - DOI - PubMed
    1. Carbone A., Al Salhi Y., Tasca A., Palleschi G., Fuschi A., De Nunzio C., Bozzini G., Mazzaferro S., Pastore A.L. Obesity and kidney stone disease: A systematic review. Minerva Urol. Nefrol. 2018;70:393–400. doi: 10.23736/S0393-2249.18.03113-2. - DOI - PubMed